KDM1A and acute lymphoblastic leukemia: Our prior LSD1 inhibitor, S2157, effectively eliminated leukemia cells in the central nervous system of mice transplanted with T-cell acute lymphoblastic leukemia cells, as it successfully crossed the blood-brain barrier [26].